NCT03024905

Brief Summary

The purpose of this trial is to establish if several interventions will help women in rural Tanzania access health care services during pregnancy and at the time of delivery. The interventions include education about the importance of attending antenatal care visits with nurses and facility deliveries, a voucher for transport to access the health facility at the time of delivery, and supplies to be used either at the health facility, or on route if the women does not make it to the health facility.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

January 16, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 19, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

August 9, 2019

Status Verified

August 1, 2019

Enrollment Period

2.3 years

First QC Date

December 11, 2016

Last Update Submit

August 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Facility births

    Number of women attending health facilities for delivery

    During baseline vs during intervention periods until end of study (2 years)

Secondary Outcomes (4)

  • Antenatal Care visits

    During baseline vs during intervention until end of study (2 years)

  • Postpartum visits

    During baseline vs during intervention until end of study (2 years)

  • Use of transport intervention

    During Intervention until end of study (2 years)

  • Use of birth kit

    During Intervention until end of study (2 years)

Study Arms (4)

Division 1

EXPERIMENTAL

The first division receives baseline data collection for 6 months then experiences interventions for the remainder of the trial. Interventions are behavioural and device: Behavioural: education about safety of delivery at a health facility, reminders to go for antenatal care, and a voucher for transport to the health facility at the time of delivery. Device: A birth kit with clean delivery supplies (soap, 2 pairs of gloves, cord clamps, surgical blade, and 600 mcg misoprostol for the woman to take immediately after the delivery to prevent postpartum hemorrhage).

Behavioral: Village meeting and travel vouchersDevice: Birth kit with misoprostol

Division 2

EXPERIMENTAL

The second division receives baseline data collection for 9 months then experiences interventions for the remainder of the trial. Interventions are behavioural and device: Behavioural: education about safety of delivery at a health facility, reminders to go for antenatal care, and a voucher for transport to the health facility at the time of delivery. Device: A birth kit with clean delivery supplies (soap, 2 pairs of gloves, cord clamps, surgical blade, and 600 mcg misoprostol for the woman to take immediately after the delivery to prevent postpartum hemorrhage).

Behavioral: Village meeting and travel vouchersDevice: Birth kit with misoprostol

Division 3

EXPERIMENTAL

The third division receives baseline data collection for 12 months then experiences interventions for the remainder of the trial. Interventions are behavioural and device: Behavioural: education about safety of delivery at a health facility, reminders to go for antenatal care, and a voucher for transport to the health facility at the time of delivery. Device: A birth kit with clean delivery supplies (soap, 2 pairs of gloves, cord clamps, surgical blade, and 600 mcg misoprostol for the woman to take immediately after the delivery to prevent postpartum hemorrhage).

Behavioral: Village meeting and travel vouchersDevice: Birth kit with misoprostol

Division 4

EXPERIMENTAL

The fourth division receives baseline data collection for 15 months then experiences interventions for the remainder of the trial. nterventions are behavioural and device: Behavioural: education about safety of delivery at a health facility, reminders to go for antenatal care, and a voucher for transport to the health facility at the time of delivery. Device: A birth kit with clean delivery supplies (soap, 2 pairs of gloves, cord clamps, surgical blade, and 600 mcg misoprostol for the woman to take immediately after the delivery to prevent postpartum hemorrhage).

Behavioral: Village meeting and travel vouchersDevice: Birth kit with misoprostol

Interventions

The interventions are: 1. Village meetings by community health workers to educate women and their families about safe birthing. 2. Vouchers for free transport by motorcycle taxi drivers to access health facility at delivery.

Division 1Division 2Division 3Division 4

Provision of birth kit with clean delivery supplies (soap, 2 pairs of gloves, 2 cord clamps, surgical blade, and 600 mcg misoprostol for the woman to take immediately after the delivery to prevent postpartum hemorrhage).

Division 1Division 2Division 3Division 4

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women must be pregnant.
  • Women must live in Rorya District, but not in Shirati Town.
  • Women must deliver in Rorya District .

You may not qualify if:

  • Women who live outside or deliver outside of Rorya District.
  • Women who deliver preterm, before they have exposure to all the interventions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shirati District Hospital Research Office

Shirati, Rorya District, Mara, Tanzania

Location

Related Publications (1)

  • Webber G, Chirangi B, Magatti N, Mallick R, Taljaard M. Improving health care facility birth rates in Rorya District, Tanzania: a multiple baseline trial. BMC Pregnancy Childbirth. 2022 Jan 27;22(1):74. doi: 10.1186/s12884-022-04408-5.

MeSH Terms

Conditions

Maternal Death

Condition Hierarchy (Ancestors)

Parental DeathDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Bwire Chirangi, MPH

    Director of Shirati KMT Hospital

    PRINCIPAL INVESTIGATOR
  • Gail C Webber, MD, PhD

    Bruyère Health Research Institute.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Scientist

Study Record Dates

First Submitted

December 11, 2016

First Posted

January 19, 2017

Study Start

January 16, 2017

Primary Completion

May 1, 2019

Study Completion

May 1, 2019

Last Updated

August 9, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations